REVIVA PHARMACEUTICALS HOLDINGS, INC. - RVPH

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 03, 2026 SCHEDULE 13G/A Integrated Core Strategies (US) LLC 8.2% 1,072,690 View
Aug 03, 2026 SCHEDULE 13G/A Millennium Management LLC 8.2% 1,072,690 View
Aug 03, 2026 SCHEDULE 13G/A Millennium Group Management LLC 8.2% 1,072,690 View
Aug 03, 2026 SCHEDULE 13G/A Israel A. Englander 8.2% 1,072,690 View
Jul 31, 2026 SCHEDULE 13G/A UBS Group AG 0.0% 0 View
May 15, 2026 SCHEDULE 13G/A CVI Investments, Inc. 4.9% 672,811 View
May 15, 2026 SCHEDULE 13G/A Heights Capital Management, Inc. 4.9% 672,811 View
May 07, 2026 SCHEDULE 13G UBS Group AG 5.8% 746,095 View
Mar 30, 2026 SCHEDULE 13G Integrated Core Strategies (US) LLC 6.2% 793,952 View
Mar 30, 2026 SCHEDULE 13G Millennium Management LLC 6.2% 793,952 View
Mar 30, 2026 SCHEDULE 13G Millennium Group Management LLC 6.2% 793,952 View
Mar 30, 2026 SCHEDULE 13G Israel A. Englander 6.2% 793,952 View
Mar 25, 2026 SCHEDULE 13G CVI Investments, Inc. 5.2% 666,667 View
Mar 25, 2026 SCHEDULE 13G Heights Capital Management, Inc. 5.2% 666,667 View
Mar 24, 2026 SCHEDULE 13D/A 2.8% View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.